Ionis Pharmaceuticals (IONS) Earnings Date, Estimates & Call Transcripts $33.65 +0.87 (+2.65%) Closing price 04:00 PM EasternExtended Trading$33.40 -0.25 (-0.74%) As of 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ionis Pharmaceuticals Earnings Summary Latest Q1 Earnings DateApr. 30EstimatedConsensus EPS (Apr. 30) -$1.07 Actual EPS (Apr. 30) -$0.93 Beat By $0.14 Actual Revenue (Apr. 30) $132.00MIonis Pharmaceuticals posted Q1 2025 earnings on April 30, 2025, reporting an EPS of -$0.93, which topped the consensus estimate of -$1.07 by $0.14. Quarterly revenue rose 10.9% year-over-year to $132 million, below analysts' expectations of $144.31 million. With a trailing EPS of -$2.99, Ionis Pharmaceuticals' earnings are expected to grow next year, from ($3.50) to ($2.41) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)Slide DeckFull Screen Slide DeckPowered by Get Ionis Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ionis Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIONS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IONS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ionis Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20254-$1.23-$1.04-$1.15Q2 20254-$1.02-$0.76-$0.91Q3 20254-$0.93-$0.83-$0.89Q4 20253-$0.78-$0.73-$0.76 FY 2025 15 -$3.96 -$3.36 -$3.71 Q1 20262-$0.80-$0.70-$0.75Q2 20262-$0.73-$0.60-$0.67Q3 20262-$0.72-$0.43-$0.58Q4 20262-$0.62-$0.39-$0.51 Ionis Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails4/30/2025Q1 2025-$1.07-$0.93+$0.14-$0.93$144.31M$132.00M2/19/2025Q4 2024-$1.12-$0.66+$0.46-$0.66$140.97M$227.00M8/1/2024Q2 2024-$0.92-$0.45+$0.47-$0.45$152.35M$225.00M5/7/2024Q1 2024-$1.10-$0.98+$0.12-$0.98$131.42M$119.00M2/21/2024Q4 2023-$0.78-$0.06+$0.72-$0.06$176.01M$325.00M11/2/2023Q3 2023-$1.01-$1.03 -$0.02-$1.03$139.42M$144.00M8/9/2023Q2 2023-$0.94$0.60+$1.54$0.60$136.84M$188.00M Ionis Pharmaceuticals Earnings - Frequently Asked Questions When did Ionis Pharmaceuticals announce their last quarterly earnings? Ionis Pharmaceuticals (NASDAQ:IONS) last announced its quarterly earning data on Wednesday, April 30, 2025. Learn more on IONS's earnings history. What guidance has Ionis Pharmaceuticals issued on next quarter's earnings? Ionis Pharmaceuticals updated its FY 2025 earnings guidance on Wednesday, April, 30th. The company issued revenue guidance of $725.0 million-$750.0 million, compared to the consensus revenue estimate of $653.5 million. Did Ionis Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Ionis Pharmaceuticals (NASDAQ:IONS) reported ($0.93) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.07) by $0.14. Learn more on analysts' earnings estimate vs. IONS's actual earnings. How can I listen to Ionis Pharmaceuticals's earnings conference call? The conference call for Ionis Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Ionis Pharmaceuticals's conference call transcript? The conference call transcript for Ionis Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Ionis Pharmaceuticals generate each year? Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded annual revenue of $705.14 million. How much profit does Ionis Pharmaceuticals generate each year? Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded net income of -$366.29 million. IONS has generated -$2.99 earnings per share over the last four quarters. What is Ionis Pharmaceuticals's EPS forecast for next year? Ionis Pharmaceuticals's earnings are expected to grow from ($3.50) per share to ($2.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies BIIB Earnings Date UTHR Earnings Date BMRN Earnings Date INCY Earnings Date EXEL Earnings Date NBIX Earnings Date EXAS Earnings Date RGEN Earnings Date HALO Earnings Date MDGL Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan This page (NASDAQ:IONS) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ionis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IONS Stock Free IONS Stock Alerts